Penny Stock InMed Pharmaceuticals Merger Deal Targets Migraine Pipeline

InMed Pharmaceuticals Inc. (NASDAQ:INM) shares are up during Tuesday's premarket session, as the company announced a merger agreement with Mentari Therapeutics.